Latest News Releases From The Newsroom
Breaking: Asset Sale Deal Ignites Avalo Therapeutics
September 12th, 2023
Shares of Avalo Therapeutics, Inc. (Nasdaq: AVTX) surged by more than 40% following the company's announcement of a purchase agreement with AUG Therapeutics, LLC (AUG), wherein it will sell its rights, assets, and interests related to the 800 Series . Read more
Sight Sciences Takes a Hit: Revenue Outlook Falls Short
September 11th, 2023
Shares of Sight Sciences, Inc. (Nasdaq: SGHT) took a sharp nosedive in after-hours trading, plummeting over 15%. This drastic drop followed the company's announcement that its third-quarter 2023 total revenue is expected to be in the range of $19.0 m. Read more
Earnings Reaction Rollercoaster: Oracle Tumbles, Casey's Surges
September 11th, 2023
Oracle Corporation (NYSE: ORCL), a global technology company, reported first-quarter fiscal 2024 earnings of $1.19 per share, surpassing the consensus EPS estimate of $1.15. However, the company's quarterly revenues of $12.45 billion fell slightly be. Read more
FTC Says TruthFinder, Instant Checkmate Deceived Users About Background Report Accuracy, Violated FCRA While Marketing Reports for Employee and Tenant Screening
September 11th, 2023
Under proposed order, companies will pay $5.8 million penalty, implement FCRA monitoring program Washington D.C. / CRWE PRESS RELEASE / September 11, 2023 - The Federal Trade Commission will require background report providers TruthFind. Read more
FuelCell Energy Posts Mixed Results; Bullish View On Kenvue
September 11th, 2023
FuelCell Energy, Inc. (Nasdaq: FCEL), a renewable energy company, reported a third-quarter fiscal 2023 loss of $(0.06) per share, better than the consensus estimate loss of $(0.08). The company's quarterly sales amounted to $25.51 million, slightly b. Read more
Momentum: Crinetics' Acromegaly Study Data and Tesla's Morgan Stanley Boost
September 11th, 2023
Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) has reported promising results from its Phase 3 PATHFNDR-1 study evaluating paltusotine, an oral once-daily investigational compound designed for acromegaly treatment. The study achieved its primary endp. Read more
Upcoming Earnings: High Tide, eGain, and iPower Take the Stage
September 11th, 2023
Some of the companies expected to report financial results on Thursday, September 14, are: High Tide Inc. (Nasdaq: HITI), a company in the cannabis industry, will release its financial and operational results for the third fiscal quarter of 2023 a. Read more
Earnings Due: Adobe, Copart, and Mitek Systems Set to Unveil
September 10th, 2023
Several companies are set to report their financial results on Thursday, September 14, including: Adobe Inc. (Nasdaq: ADBE), a renowned software company, is scheduled to release its third-quarter fiscal year 2023 results after the market closes.&n. Read more
Breaking Biotech Newsflash: Amgen, Gilead Sciences, and Merck
September 10th, 2023
Amgen Inc. (Nasdaq: AMGN) unveiled encouraging data from the CodeBreaK 101 clinical trial, showcasing the effectiveness of LUMAKRAS (sotorasib) plus chemotherapy (carboplatin and pemetrexed) in treating KRAS G12C-mutated advanced non-small cell lung . Read more
Earnings Countdown: InnovAge, Evolution Petroleum, and Edgio in the Spotlight
September 09th, 2023
Some of the companies expected to report financial results on Tuesday, September 12, are: InnovAge Holding Corp. (Nasdaq: INNV), a healthcare services provider, will be releasing its 2023 fiscal fourth-quarter financial results following the marke. Read more
Want To Find Some News?
News By Industries
Recent Posts
-
NJCP Football League Provides Development and Opportunity for Athletes Pursuing the Next Level
March 20th, 2026March 19th, 2026How High School Graduates Can Kickstart Their Football Career
March 18th, 2026




Member Login